Experts Say Resuming Use Of Johnson & Johnson COVID-19 Vaccine Will Require Clear Guidelines On How To Treat Patients With Rare Blood Clots And Telltale Symptoms For Recipients To Look For

Reuters (4/19, Beasley) reports, “Resuming the use of Johnson & Johnson’s COVID-19 vaccine in the United States will require clear guidelines for the medical community on how to best treat patients that develop a rare type of blood clot, as well as alerti...